Anina Adelfio is the Chief Operating Officer for ACRO. She has been with ACRO since 2015 and in her current role since 2022. Anina works closely with ACRO’s Risk-Based Quality Management (RBQM) team and leads ACRO’s Crisis Response Team. She runs a five-year long project assessing how RBQM principles are applied and utilized in clinical trials. In 2020, she focused on ACRO’s response to the COVID-19 pandemic. In addition, she oversees a number of collaborations that ACRO has with Regulators and other stakeholder groups in the clinical trial industry. Anina earned a BA from the University of Maryland and is currently pursuing a Masters of Regulatory Affairs from the University of Pennsylvania.
